Medtronic starts marketing artificial pancreas (type -1 diabetes).

Medtronic issued a press release announcing it will launch its “hybrid closed-loop system” artificial pancreas on the US market. The system, named MiniMed 670G, is an insulin pump approved by FDA, which ensures – through a specific algorithm, that basal insulin levels are maintained in blood in patients with type -1 diabetes.
(Source: Medtronic)